Luigi Buonaguro

Systems biology applied to vaccine and immunotherapy development

Francesco M. Marincola, Luigi Buonaguro, Ena Wang, 2011, BMC Systems Biology.

Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation

Francesco M. Marincola, Luigi Buonaguro, Ena Wang, 2008, BMC Bioinformatics.

HIV‐1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix‐associated heparan sulfate proteoglycans through its basic region

Luigi Buonaguro, L. Buonaguro, B. Ensoli, 1997, AIDS.

VLPs and particle strategies for cancer vaccines

Claudia Conte, Francesca Ungaro, Fabiana Quaglia, 2013, Expert review of vaccines.

Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?

Gennaro Ciliberto, Luigi Buonaguro, Peter Brauchli, 2016, Cancer treatment reviews.

Conformational HIV-1 Envelope on particulate structures: a tool for chemokine coreceptor binding studies

Luigi Buonaguro, Maria Lina Tornesello, Franco M Buonaguro, 2011, Journal of Translational Medicine.

Developments in virus-like particle-based vaccines for HIV

Luigi Buonaguro, Maria Lina Tornesello, Franco M Buonaguro, 2013, Expert review of vaccines.

Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma

Luigi Buonaguro, Maria Lina Tornesello, Franco M Buonaguro, 2017, Infectious Agents and Cancer.